These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32632753)

  • 1. Bridging the Gap Between RCTs and RWE Through Endpoint Selection.
    LoCasale RJ; Pashos CL; Gutierrez B; Dreyer NA; Collins T; Calleja A; Seewald MJ; Plumb JM; Liwing J; Tepie MF; Khosla S
    Ther Innov Regul Sci; 2021 Jan; 55(1):90-96. PubMed ID: 32632753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening pharma's contract with society: the value of trusted partnerships between pharma and healthcare facilitated by real-world data.
    Seewald MJ; Plumb JM; Gutierrez B; Liwing J; Tepie MF; Hammer M; LoCasale R; Khosla S; Yin D; Pashos CL; Nagy M
    J Comp Eff Res; 2020 Feb; 9(3):155-159. PubMed ID: 31964167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process.
    Zisis K; Pavi E; Geitona M; Athanasakis K
    J Pharm Pharm Sci; 2024; 27():12302. PubMed ID: 38481726
    [No Abstract]   [Full Text] [Related]  

  • 4. Examining Endpoint Concordance in Clinical Trials and Real-World Clinical Practice to Advance Real-World Evidence Utilization.
    Schaumberg D; Larholt K; Apgar E; Pashos CL; Hirsch G
    Ther Innov Regul Sci; 2023 May; 57(3):472-475. PubMed ID: 36624361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Bayesian Evidence Synthesis Methods to Incorporate Real-World Evidence in Surrogate Endpoint Evaluation.
    Wheaton L; Papanikos A; Thomas A; Bujkiewicz S
    Med Decis Making; 2023 Jul; 43(5):539-552. PubMed ID: 36998240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
    Webster J; Smith BD
    Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of Randomized, Controlled Trials Using Real-World Data: What Could Go Wrong?
    Thompson D
    Value Health; 2021 Jan; 24(1):112-115. PubMed ID: 33431143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.
    Franklin JM; Patorno E; Desai RJ; Glynn RJ; Martin D; Quinto K; Pawar A; Bessette LG; Lee H; Garry EM; Gautam N; Schneeweiss S
    Circulation; 2021 Mar; 143(10):1002-1013. PubMed ID: 33327727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea.
    Lee H; Ahn HS; Kwon S; Kang HY; Han E
    Clin Transl Sci; 2024 Apr; 17(4):e13801. PubMed ID: 38629484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements.
    Sievers H; Joos A; Hiligsmann M
    Int J Technol Assess Health Care; 2021 Feb; 37():e40. PubMed ID: 33622423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximizing the Value of Real-World Data and Real-World Evidence to Accelerate Healthcare Transformation in China: Summary of External Advisory Committee Meetings.
    Sun F; Bedenkov A; Liu BC; Yang J; Xu JF; Ji L; Zhou M; Zhang S; Li X; Song Y; Chen P; Moreno C
    Pharmaceut Med; 2024 May; 38(3):157-166. PubMed ID: 38573457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
    Wu J; Wang C; Toh S; Pisa FE; Bauer L
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Expanding Role of Real-World Evidence Trials in Health Care Decision Making.
    Klonoff DC
    J Diabetes Sci Technol; 2020 Jan; 14(1):174-179. PubMed ID: 30841738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial designs using real-world data: The changing landscape of the regulatory approval process.
    Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical Considerations on the Use of RWD/RWE for Oncology Drug Approvals: Overview and Lessons Learned.
    Ro SK; Zhang W; Jiang Q; Li XN; Liu R; Lu CC; Marchenko O; Sun L; Zhao J
    Ther Innov Regul Sci; 2023 Jul; 57(4):899-910. PubMed ID: 37179264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Pharmacology Applications of Real-World Data and Real-World Evidence in Drug Development and Approval-An Industry Perspective.
    Zhu R; Vora B; Menon S; Younis I; Dwivedi G; Meng Z; Datta-Mannan A; Manchandani P; Nayak S; Tammara BK; Garhyan P; Iqbal S; Dagenais S; Chanu P; Mukherjee A; Ghobadi C;
    Clin Pharmacol Ther; 2023 Oct; 114(4):751-767. PubMed ID: 37393555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using RWE research to extend clinical trials in diabetes: An example with implications for the future.
    Seeger JD; Nunes A; Loughlin AM
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 3(Suppl 3):35-44. PubMed ID: 32250529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication of randomized clinical trial results using real-world data: paving the way for effectiveness decisions.
    Sheffield KM; Dreyer NA; Murray JF; Faries DE; Klopchin MN
    J Comp Eff Res; 2020 Oct; 9(15):1043-1050. PubMed ID: 32914653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Real-world evidence and randomized controlled trials: the initiation, implementation, progress interpretation and revelation of RCT DUPLICATE (part 1)].
    Shi SY; Liu ZX; Zhao HY; Nie XL; Fu Z; Song HB; Yao C; Zhan SY; Sun F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Nov; 43(11):1828-1834. PubMed ID: 36444469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reality check: Real-world evidence to support therapeutic development in hematologic malignancies.
    Derman BA; Belli AJ; Battiwalla M; Hamadani M; Kansagra A; Lazarus HM; Wang CK
    Blood Rev; 2022 May; 53():100913. PubMed ID: 35272867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.